1. Home
  2. ONL vs GNLX Comparison

ONL vs GNLX Comparison

Compare ONL & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.62

Market Cap

165.4M

Sector

Real Estate

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$3.01

Market Cap

133.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONL
GNLX
Founded
2021
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.4M
133.0M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ONL
GNLX
Price
$2.62
$3.01
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.00
$17.25
AVG Volume (30 Days)
187.4K
145.4K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
9.47
EPS
N/A
N/A
Revenue
$147,647,000.00
$8,000.00
Revenue This Year
$4.10
N/A
Revenue Next Year
$3.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$2.29
52 Week High
$3.04
$8.54

Technical Indicators

Market Signals
Indicator
ONL
GNLX
Relative Strength Index (RSI) 43.63 43.80
Support Level $2.62 $2.74
Resistance Level $2.71 $2.98
Average True Range (ATR) 0.07 0.12
MACD -0.00 -0.01
Stochastic Oscillator 36.36 20.75

Price Performance

Historical Comparison
ONL
GNLX

About ONL Orion Office REIT Inc.

Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: